Asset Publisher

GCC Drug Pricing Committee Meets in Oman

GCC Drug Pricing Committee Meets in Oman

GCC Drug Pricing Committee Meets in Oman


The 33rd meeting of the Gulf Cooperation Council (GCC) drug pricing committee started today (Monday). The three-day meeting, hosted by the Sultanate, was attended by Dr. Khaled Mohammed Al Mashaikhi, Director General for Health Services in Dhofar, stressed in his inaugural speech the significance of the meeting and the issues it would discussed accordingly.

The opening program further reviewed the important role that the committee played in the last period including the achievements made in the field of drug price reduction and provision.

Dr. Mohammed Hamdan Al Rubai’e, Director General of Pharmaceutical Affairs and Drug Control at the MOH highlighted the unification of medicine prices in GCC countries and emphasizing the private sector role. He additionally underlined challenges regarding the increasing prices of drugs.

The meeting agenda, held in Salalah Rotana Resort, includes spectrum of topics that contain a discussion of the ministerial and executive decisions and recommendations concerning the organization of the committee’s work, remarks made by firms, as well as the actions completed regarding the pricing of pending pharmaceutical products.

Moreover, the meeting will review the GCC Pricing Guidelines study and discuss the unification of the pharmaceutical products prices provided from the Sultanate and Saudi Arabia, in addition to the committee meeting and agenda for the next period.